
Inrab 10mg Tablet
Marketer
Veritaz Healthcare Ltd
Salt Composition
Rabeprazole (10mg)
Overview Inrab 10mg Tablet
Gastric acid production is diminished by the 10mg Inrab tablet, a medication indicated for stomach and intestinal disorders stemming from excess acid. These include acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and facilitating healing. Administer one 10mg tablet an hour prior to meals, ideally in the morning, adhering to your physician's prescribed dosage and schedule for optimal results. Consistent use is crucial, even with rapid symptom improvement. Dietary adjustments—smaller, more frequent meals, avoidance of caffeine, spicy foods, and fatty foods—can complement treatment. Common, typically mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Report persistent or bothersome effects to your doctor. Prolonged use (exceeding one year), especially at higher doses, elevates the risk of fractures. Discuss bone health preservation strategies, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) has been observed in some patients after three months or more of use; symptoms include fatigue, confusion, vertigo, muscle spasms, and arrhythmia. Magnesium levels may be monitored accordingly. Prior to commencing treatment, inform your doctor of severe liver impairment, HIV medication use, prior allergic reactions to similar drugs, or existing osteoporosis. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to its acid-inducing properties. Refrain from operating machinery or driving if drowsiness or dizziness occur.
Uses of Inrab 10mg Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Inrab 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 10mg Inrab tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Inrab 10mg Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Inrab 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume the Inrab 10mg Tablet on an empty stomach.
How Inrab 10mg Tablet works:
Inrab 10mg tablets function as a proton pump inhibitor, decreasing stomach acid production to alleviate heartburn and acid indigestion symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Inrab 10mg Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Using Inrab 10mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Inrab 10mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 10mg Inrab tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Inrab 10mg tablets pose no safety concerns for individuals with kidney impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Inrab 10mg tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Inrab 10mg Tablet :
Should you forget to take your Inrab 10mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Inrab 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
